Oviva Therapeutics
Dr. Thompson is a Professor in the Department of Molecular and Cellular Biosciences at the University of Cincinnati, College of Medicine. He studies the structure and function of several TGFb family members, including AMH, where his laboratory was the first to determine the structure of AMH bound to the type II receptor, AMHR2. Dr. Thompson received his PhD from the Biochemistry Department at the University of Wisconsin Madison and completed a post-doctoral fellowship at Northwestern University.
This person is not in the org chart
This person is not in any offices
Oviva Therapeutics
Oviva Therapeutics is a biotechnology company driving forward R&D in women's health and ovarian physiology with an aim to improve healthspan in women. They are currently in advanced preclinical stage for a therapeutic targeting protection of the ovarian reserve and extension of ovarian function.